Orthopedic Industry Exhibits Steady Transactional Activity and Value, Despite Maturity

Orthopedic Industry Exhibits Steady Transactional Activity and Value, Despite Maturity

Published in MedTech Strategist

Author: Wendy Diller

Abstract:
Investors and entrepreneurs in recent years have gravitated away from orthopedics and medtech in general, toward splashier, hyper-growth subsectors of the life sciences, such as biotech and digital health. Outcome Capital argues that the industry—and ortho in particular—remains highly attractive, as it offers investors and entrepreneurs stability, healthy multiples, and opportunities for innovation.